Cathepsin B (CTSB) expression was significantly reduced in both primary cancer tissue and metastatic cancer tissue when compared to non-malignant prostate tissue (P ≤ 0.01; Figure 1). The gene discussed is CTSB; the disease is metastatic malignant neoplasm.